Vanguard Wellington™ Fund Investor Shares (VWELX)

44.14
Net Asset Value
+0.23%
1 Day
+18.91%
Year-to-Date
Overall Morningstar Rating
Allocation--50% to 70% equity
Style or Category
No Load
Sales Expenses
0.25%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide long-term capital appreciation and moderate current income. The fund invests 60% to 70% of its assets in dividend-paying and, to a lesser extent, non-dividend-paying common stocks of established large companies. The remaining 30% to 40% of the fund's assets are invested mainly in fixed income securities that the advisor believes will generate a moderate level of current income. These securities include investment-grade corporate bonds, with some exposure to U.S. Treasury and government agency bonds, and mortgage-backed securities.

Performance

1 month+1.87% 3 years+10.10%
3 months+4.38% 5 years+8.68%
1 year+18.26% Since inception+8.28%
Data through --

Peer Comparisonvs. Allocation--50% to 70% equity

 VWELXCategory
Performance 5-yr return+8.68%+5.60%
Expense ratio0.25%1.10%
Risk 5 year sharpe ratio0.940.62
Net assets$110.7B$3.6B
Average market cap$131.6B$80.2B
Average P/E17.619.5
Portfolio turnover34%34%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyVanguard
Fund manager & tenureEdward Bousa / 16 Years
Minimal initial investment$3,000.00
Minimum IRA investment--

Holdings

U.S. stock52.55%
Fixed income32.76%
International stock11.43%
Cash2.70%
Other0.57%
Top 5 Sectors
Portfolio weighting
Financial service 17.63%
Healthcare 14.44%
Energy 13.83%
Industrial materials 13.39%
Consumer goods 8.60%
Top 10 Holdings
Portfolio weighting
MSFT Microsoft3.24%
VZ Verizon2.51%
JPM JPMorgan Chase2.39%
BAC Bank of America2.15%
GOOGL Google2.00%
CMCSA Comcast1.78%
-- 1.63%
CVX Chevron1.58%
MDT Medtronic PLC1.26%
AZN AstraZeneca1.18%